These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3115874)

  • 21. The antibody-independent cytotoxic activity of normal circulating human leucocytes. I. Lysis of target cells by monocytes and neutrophils in a non-phagocytic pathway.
    Banerjee D; Fernando L; Sklar S; Richter M
    Immunology; 1981 Sep; 44(1):97-107. PubMed ID: 7275189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The antibody-independent cytotoxic activity of normal circulating human leucocytes. II. Failure to demonstrate effector cell-target cell interaction and target cell specificity of the circulating cytotoxic-enhancing factor.
    Richter M; Banerjee D; Sklar S
    Immunology; 1981 Sep; 44(1):109-18. PubMed ID: 6944271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphocyte supernatant-induced human monocyte tumoricidal activity: dependence on the presence of gamma-interferon.
    Sadlik JR; Hoyer M; Leyko MA; Horvat R; Parmely M; Whitacre C; Zwilling B; Rinehart JJ
    Cancer Res; 1985 May; 45(5):1940-5. PubMed ID: 3921233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of E-rosette formation and phagocytosis by human blood leucocytes after treatment with the dengue virus-induced cytotoxic factor.
    Chaturvedi UC; Gulati L; Mathur A
    Immunology; 1982 Apr; 45(4):679-85. PubMed ID: 6978284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphokine-mediated secretion of a suppressor factor by monocytic cells derived from human adult peripheral blood.
    Hayamizu K; Yahata H; Fukuda Y; Okimoto T; Dohi K
    Transplant Proc; 1994 Aug; 26(4):1866-7. PubMed ID: 8066606
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro studies on the interaction of human monocytes and the monocyte locomotion inhibitory factor produced by E. histolytica.
    Kretschmer R; Castro EM; Arellano J; Pacheco MG
    Arch Invest Med (Mex); 1986; 17 Suppl 1():243-6. PubMed ID: 2884963
    [No Abstract]   [Full Text] [Related]  

  • 27. The detection and identification of subpopulations of circulating human lymphocytes, monocytes and neutrophils capable of effecting a mitogen-induced cell-mediated cytotoxic reaction towards erythrocytes of various species.
    Cortens M; Sklar S; Richter M
    Immunology; 1980 Nov; 41(3):623-34. PubMed ID: 7461704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered monocyte functions in patients with angioimmunoblastic lymphadenopathy.
    Pálóczi K; Zeher M; Lukács K; Kávai M; Szegedi G
    Haematologia (Budap); 1987; 20(2):109-15. PubMed ID: 3653789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Augmentation of macrophage complement receptor function in vitro. II. Characterization of the effects of a unique lymphokine upon the phagocytic capabilities of macrophages.
    Griffin FM; Griffin JA
    J Immunol; 1980 Aug; 125(2):844-9. PubMed ID: 7391581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of lymphocyte migration by human lymphokines. I. Identification and characterization of chemoattractant activity for lymphocytes from mitogen-stimulated mononuclear cells.
    Center DM; Cruikshank W
    J Immunol; 1982 Jun; 128(6):2563-8. PubMed ID: 7042840
    [No Abstract]   [Full Text] [Related]  

  • 31. Surface receptors and immune activity of purified human mononuclear cells. II. The lack of correlation between rosette formation and ADCC cytotoxic activity.
    Richter M; Sklar S
    Clin Invest Med; 1983; 6(3):185-90. PubMed ID: 6652984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IFN-gamma treated monocyte/macrophage phagocytosis of red cells sensitized with IgG1 and IgG3 Anti-D containing identical immunoglobulin variable region genes.
    Perri D; Shabani F; Ziaeian G; Denomme GA
    Transfus Apher Sci; 2008 Aug; 39(1):37-44. PubMed ID: 18614400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversible defect in antigen-induced lymphokine and gamma-interferon generation in cutaneous leishmaniasis.
    Murray HW; Rubin BY; Carriero S; Acosta AM
    J Immunol; 1984 Oct; 133(4):2250-4. PubMed ID: 6432909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Stimulation of phagocytic function by factors inhibiting leukocyte and macrophage migration in humans].
    Gankovskaia LV; Tskhovrebova AZ; Gvozdeva NA; Koval'chuk LV; Cheredeev AN
    Biull Eksp Biol Med; 1986 Aug; 102(8):210-3. PubMed ID: 3527300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of interferon on ADCC (I).
    Spangsbjerg N; Heron I
    Acta Pathol Microbiol Immunol Scand C; 1983 Oct; 91(5):315-21. PubMed ID: 6659937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of mouse IgG2a- and IgG3-dependent cellular cytotoxicity in human monocytic cells (U937) by immune interferon.
    Akiyama Y; Lubeck MD; Steplewski Z; Koprowski H
    Cancer Res; 1984 Nov; 44(11):5127-31. PubMed ID: 6435864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential effect of the serine protease inhibitor phenyl methyl sulfonyl fluoride on cytochemically detectable esterases in human leucocytes and platelets.
    Dufer J; Trentesaux C; Desplaces A
    Scand J Haematol; 1984 Jan; 32(1):25-32. PubMed ID: 6364322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferons as macrophage-activating factors. III. Preferential effects of interferon-gamma on the interleukin 1 secretory potential of fresh or aged human monocytes.
    Arenzana-Seisdedos F; Virelizier JL; Fiers W
    J Immunol; 1985 Apr; 134(4):2444-8. PubMed ID: 3919095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferons as modulators of human monocyte-macrophage differentiation. I. Interferon-gamma increases HLA-DR expression and inhibits phagocytosis of zymosan.
    Becker S
    J Immunol; 1984 Mar; 132(3):1249-54. PubMed ID: 6420462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of human blood monocytes in erythrophagocytosis assay with anti-Rh antibodies.
    Brojer E; Gronkowska A; Zupańska B
    Arch Immunol Ther Exp (Warsz); 1986; 34(5-6):553-60. PubMed ID: 3496064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.